Találati lista | Tudóstér

001-es BibID:	BIBFORM101082
035-os BibID:	(cikkazonosító)771 (WoS)000786951400001 (Scopus)85128385089
Első szerző:	Nádró Bíborka (általános orvos)
Cím:	Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia / Bíborka Nádró, Hajnalka Lőrincz, Lilla Juhász, Anita Szentpéteri, Ferenc Sztanek, Éva Varga, Dénes Páll, György Paragh, Mariann Harangi
Dátum:	2022
ISSN:	2227-9059
Megjegyzések:	Abstract: Background: Familial hypercholesterolemia (FH) is an autosomal dominant trait characterized by elevated LDL-C concentrations and is associated with an increased risk of premature atherosclerosis. Progranulin (PGRN) is a multifunctional protein that is known to have various anti-atherogenic effects. To date, the use of serum PGRN in patients with FH has not been studied. Methods: In total, 81 untreated patients with heterozygous FH (HeFH) and 32 healthy control subjects were included in this study. Serum PGRN, sICAM-1, sVCAM-1, oxLDL and TNF concentrations were determined by ELISA. Lipoprotein subfractions were detected by Lipoprint. We diagnosed FH using the Dutch Lipid Clinic Network criteria. Results: We could not find a significant difference between the PGRN concentrations of the HeFH patients and controls (37.66 9.75 vs. 38.43 7.74 ng/mL, ns.). We found significant positive correlations between triglyceride, TNF , sVCAM-1, the ratio of small HDL subfraction and PGRN, while significant negative correlations were found between the ratio of large HDL subfraction and PGRN both in the whole study population and in FH patients. PGRN was predicted by sVCAM-1, logTNF and the ratio of small HDL subfraction. Conclusions: The strong correlations between HDL subfractions, inflammatory markers and PGRN suggest that PGRN may exert its anti-atherogenic effect in HeFH through the alteration of HDL composition and the amelioration of inflammation rather than through decreasing oxidative stress.
Tárgyszavak:	Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk progranulin familial hypercholesterolemia inflammation tumor necrosis factor alpha high-density lipoprotein subfraction
Megjelenés:	Biomedicines. - 10 : 4 (2022), p. 1-15. -
További szerzők:	Lőrincz Hajnalka (1986-) (biológus) Juhász Lilla (1990-) (általános orvos) Szentpéteri Anita (1988-) (biológus) Sztanek Ferenc (1982-) (orvos) Varga Éva (1982-) (belgyógyász) Páll Dénes (1967-) (belgyógyász, kardiológus) Paragh György (1953-) (belgyógyász) Harangi Mariann (1974-) (belgyógyász, endokrinológus)
Pályázati támogatás:	OTKA-115723 OTKA GINOP-2.3.2-15-2016-00062 GINOP Bridging Fund, Faculty of Medicine, University of Debrecen - HM Egyéb
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM110898
035-os BibID:	(cikkazonosító)1218 (WoS)000977128900001 (Scopus)85153720382
Első szerző:	Nagy Nikolett (belgyógyász)
Cím:	Changes in Clinical Manifestations and Course of Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome over Three Decades / Nagy Nikolett, Papp Gábor, Gáspár-Kiss Eszter, Diószegi Ágnes, Tarr Tünde
Dátum:	2023
ISSN:	2227-9059
Megjegyzések:	Systemic lupus erythematosus (SLE) is often associated with antiphospholipid syndrome (APS), which potentially results in a more severe disease course and reduced life expectancy. Since the therapeutic guidelines have been refined in the last 15 years, we assumed that the diseases course has become more favorable. In order to shed light on these achievements, we compared the data of SLE patients diagnosed before and since 2004. In our retrospective study, we assessed a wide spectrum of clinical and laboratory data of 554 SLE patients who received regular follow-up care and therapy at our autoimmune center. Among these patients, 247 had antiphospholipid antibodies (APAs) without clinical signs of APS, and 113 had definitive APS. In the APS group, among patients diagnosed since 2004, deep vein thrombosis (p = 0.049) and lupus anticoagulant positivity (p = 0.045) were more frequent, while acute myocardial infarction was less frequent (p = 0.021) compared with patients diagnosed before 2004. Among the APA positive patients without definitive APS, anti-cardiolipin antibody positivity (p = 0.024) and development of chronic renal failure (p = 0.005) decreased in patients diagnosed since 2004. Our study demonstrates that the disease course has changed in recent years; however, in the presence of APS, we have to expect repeated thrombotic events despite adequate anticoagulant therapy.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk systemic lupus erythematosus antiphospholipid syndrome disease course therapy
Megjelenés:	Biomedicines. - 11 : 4 (2023), p. 1-10. -
További szerzők:	Papp Gábor (1984-) (belgyógyász) Gáspár-Kiss Eszter (1997-) (rezidens) Diószegi Ágnes (1987-) (belgyógyász) Tarr Tünde (1976-) (belgyógyász, allergológus és klinikai immunológus)
Pályázati támogatás:	K 124177 NKFIH
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: